Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, POEMS Syndrome

NCT03717844 2025-11-20

Registry for Adults With Plasma Cell Disorders (PCD's)

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Multiple Myeloma, POEMS Syndrome

NCT02921893 2025-02-12

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

Phase EARLY_PHASE1 Completed

21 enrolled

Plasma cell

Plasmacytoma, POEMS Syndrome

NCT04561557 2024-10-30

CARTinNS

Phase EARLY_PHASE1 Recruiting

36 enrolled

Plasma cell

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, POEMS Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT05283993 2022-04-25

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting

2,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, POEMS Syndrome

NCT01816620 2017-04-25

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Phase 2 Completed

41 enrolled

Plasma cell

POEMS Syndrome, Neoplasms, Plasma Cell

Clinical Trials

ALPS

Registry for Adults With Plasma Cell Disorders (PCD's)

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

CARTinNS

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome